Duaer

Guides

2027 Clinical Trial LLMs: Which Use Cases to Pilot First

Adapted from the Duaer documentation site, this article reviews common clinical trial LLM use cases and explains how to rank them by value, data readiness, risk, and review cost, so teams can choose a first pilot that produces a clear answer within one quarter.

Common Use Cases

Most clinical operations teams have heard the pitch: an LLM can read protocols, summarize site documents, screen patients, and draft regulatory text. The hard question is not whether a model can do these things in a demo. It is which use case should receive the first budget, the first team, and the first six months of attention. Many teams start with the most impressive demonstration and end up with a tool that reads well but cannot be checked, audited, or connected to the workflow steps that actually slow a study down.

Candidate use cases at most sponsors and contract research organizations fall into a few groups. Each group touches a different part of the trial lifecycle and carries a different kind of risk.

The first group is document-centric drafting and summarization. This includes impact summaries for protocol amendments, investigator brochure updates, sections of clinical study reports, and plain-language summaries for participants. The model works from named source documents, and a qualified person reviews the output.

The second group is retrieval and question answering over internal material. Examples include helping a study team find the relevant clause in a monitoring plan, or letting a site coordinator check which visit windows apply to a given cohort. Every answer has to trace back to the original text.

The third group is patient matching and eligibility screening. The model reads structured and unstructured medical records and flags patients who may meet the protocol's inclusion and exclusion criteria. The value can be high, but so is the sensitivity, and the approach depends heavily on the quality of the underlying data. We have a separate guide on why eligibility data often blocks these projects, which is worth reading before you commit to this use case: see '2027 Clinical Trial Matching with LLMs: Why Eligibility Data Breaks First', available at https://doc.duaer.com/guides/clinical-trial-matching-llm/ .

The fourth group is operational triage. Examples include classifying deviation reports, routing data management queries, or drafting first-pass narratives for safety reviewers. This work is closer to daily workload and easier to measure, but a misclassification can slow an entire study.

The fifth group is site feasibility assessment and literature scanning. A model can help compare historical enrollment across sites or summarize published evidence in a therapeutic area. Outputs are advisory, so the cost of an error is usually lower, but the value is often harder to attribute.

Why Ranking Is Harder Than It Looks

A common mistake is to rank use cases by how exciting they sound to senior leaders. Patient matching sounds transformative, so it gets placed first. The team then discovers that sites do not share patient identifiers, that eligibility criteria are written as free text with local exceptions, and that privacy review takes longer than development. The project is not wrong in principle, but it is wrong as a first step.

A second mistake is treating value as a single number. In clinical work, value usually takes one of three forms: a document cycle that gets shorter, fewer rounds of rework, or problems caught earlier. If a use case does not map to one of these, it will be hard to defend when the pilot ends.

A third mistake is underestimating review burden. Even when a model drafts a section of a clinical study report, a qualified reviewer still has to check each statement against the source data. If that reviewer's time is not counted as a cost, the apparent time savings disappear.

A Simple Scoring Method

Build a table with one row per candidate use case. Score each on four dimensions, from 1 to 5.

Value: How many hours or weeks could it save on a recurring task, and how often does that task occur? A task that happens once per study scores lower than one that recurs weekly across many studies.

Data readiness: Are the source documents electronic, version-controlled, and easy to access? Is there a clear reference standard against which outputs can be checked?

Risk: What happens if the output is wrong and nobody notices? Anything that affects participant safety or regulatory submissions sits at the high end. Internal summaries sit at the low end.

Review cost: How much qualified human time is needed to verify each output? A high review cost does not rule a use case out, but it must be included in the value estimate.

Then rank by value minus difficulty, where difficulty combines the gap in data readiness, risk, and review cost. Use cases with high value, reasonable data readiness, and manageable risk will rise to the top. Patient matching often has high value but low data readiness, so it usually belongs in a second wave, once the data foundation has improved.

How to Choose a First Pilot

A first pilot should answer one clear question: in this workflow, can the model reduce measurable effort without introducing errors that reviewers would miss? That points toward a document-centric or retrieval-based use case with named sources and checkable answers.

A good first pilot has four features. First, the team already owns the documents and can version them. Second, a reviewer who already does this work is available to score the outputs. Third, there is a baseline that can be measured, such as the average hours per summary of amendments over the past three months. Fourth, there is a clear stopping rule. If the model does not reach the agreed accuracy threshold on a real sample of documents, the team should stop and find out why, rather than extend the project indefinitely.

Unless the organization already has mature governance, clean data, and experienced clinical sign-off, avoid starting with use cases that drive participant-level decisions. This is not because the technology cannot help. It is because in high-stakes areas, a failed first pilot often prevents an organization from returning to the use case for years.

How to Measure Whether It Works

Measure at three levels. At the output level, sample outputs each week and have a qualified reviewer record the rate of factual errors, omissions, and unsupported statements. At the workflow level, measure the time from request to approved document and count how many review rounds each document goes through. At the program level, track whether total reviewer effort falls, not just drafting time. A model that cuts drafting time but doubles review time has not actually helped.

Set these baselines before the pilot begins. Without a baseline, any result can look like progress.

What You Can Do This Week

Pick one document type that your team produces at least once a month. Collect ten recent samples, along with the final approved version of each. Record how long each one took from first draft to sign-off and how many review rounds it went through. Then, with your clinical quality assurance lead, define two or three checkable criteria, such as every number traces to a source data table, and every amendment entry maps to a specific section number. You will then have a test set and a baseline, which is a firmer starting point than most pilots have.

If you want to score a full list of candidate use cases this way and turn it into a sequenced pilot plan, you can set up this workflow in Duaer, keeping the ranking table, baseline tracking, and review records in one place. It will not decide which use case is right for you. The scores still depend on your own data and on your clinical team's judgment. What it does is give everyone involved in the decision the same consistent basis for comparison.

You can also sign up at https://www.duaer.com and try it on one real document type. A single well-measured pilot will tell you more than any vendor comparison.

The best first use of a clinical trial LLM is rarely the most ambitious one. It is the one where the data is ready, the value can be measured, the review can be managed, and the cost of failure is tolerable. Start there, measure honestly, and widen the scope once the numbers justify it.

If you tell us your specific scenario, we will send you a written rollout plan.

https://api.duaer.com/form/c59a907a-3697-4edf-a04d-3ea0fb72fdc8

Questions

Which clinical trial LLM use case should a company pilot first?

Document-centric drafting, summarization, or retrieval is usually the best place to start. These use cases have clearly named source documents, outputs can be checked line by line, the data foundation is relatively mature, and the cost of failure is manageable. Use cases that drive participant-level decisions, such as patient matching, may offer high value, but they are better tackled once data governance and clinical sign-off processes are mature.

How can you tell whether a clinical trial LLM pilot is actually working?

Establish a baseline before the pilot starts, such as the average hours and number of review rounds for a given document type over the past few months. During the pilot, measure at three levels: output accuracy, workflow cycle time, and total reviewer effort. A shorter drafting time is not enough on its own. If review time rises at the same time, overall efficiency may not have improved.

Why does eligibility data so often become the bottleneck in LLM trial projects?

Patient identifiers often differ across sites, eligibility criteria are usually written as free text with local exceptions, medical records vary widely in how structured they are, and privacy review takes a long time. As a result, projects often stall during data preparation. A safer approach is to improve the data foundation first, and then consider patient matching as a second-phase pilot.